Single-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics
Open Access
- 3 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogenesis
- Vol. 10 (3), 1-11
- https://doi.org/10.1038/s41389-021-00311-4
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, which lacks effective treatment strategies. There is an urgent need for the development of new strategies for PDAC therapy. The genetic and phenotypic heterogeneity of PDAC cancer cell populations poses further challenges in the clinical management of PDAC. In this study, we performed single-cell RNA sequencing to characterize PDAC tumors from KPC mice. Functional studies and clinical analysis showed that PDAC cluster 2 cells with highly Hsp90 expression is much more aggressive than the other clusters. Genetic and pharmacologic inhibition of Hsp90 impaired tumor cell growth both in vitro and in vivo. Further mechanistic study revealed that HSP90 inhibition disrupted the interaction between HSP90 and OPA1, leading to a reduction in mitochondrial cristae amount and mitochondrial energy production. Collectively, our study reveals that HSP90 might be a potential therapeutic target for PDAC.Keywords
Funding Information
- National Natural Science Foundation of China (81702844, 81871923)
- Shanghai Municipal Education Commission (20181708)
- Shanghai Municipal Health Bureau (201940506)
This publication has 28 references indexed in Scilit:
- Pancreatic cancerNature Reviews Disease Primers, 2016
- Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespibEuropean Journal of Cancer, 2016
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate CancerCancer Research, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Targeting the dynamic HSP90 complex in cancerNature Reviews Cancer, 2010
- HSP90 at the hub of protein homeostasis: emerging mechanistic insightsNature Reviews Molecular Cell Biology, 2010
- Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cellsCancer Biology & Therapy, 2009
- OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial FusionCell, 2006
- HSP90 and the chaperoning of cancerNature Reviews Cancer, 2005